1Ford E. S., Giles W. H., Dietz W. H.. Prevalence of the metabolic syndrome among US adults. Findings from the third National Health and Nutrition Examination Survey[J]. JAMA, 2002, 287:356-359.
3Ninomiya JK, L' Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third National Health and Nutrition Examination Survey[J]. Circulation,2004,109:42-46.
4Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women′s Ischemia Syndrome Evaluation (WISE) study[J]. Circulation,2004,109:706-713.
5Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men[J].JAMA, 2002, 288:2709-2716.
6Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome[J]. Diabetes Care, 2001,24:683-689.
7Ruige JB, Assendelft WJJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: A meta-analysis[J]. Circulation,1998,97:996-1001.
8Festa A, D'Agostino R Jr, Mykkanen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance and Atherosclerosis Study(IRAS)[J]. Aterioscler Thromb Vasc Biol, 1999; 19:562-568.
9Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW. Hyperinsulinemia, hyperglycemia and impaired hemostasis: The Framingham Offspring Study[J]. JAMA, 2000,283:221-228.
10Cavarape A, Feletto F, Mercuri F, Quagliaro L, Daman G, Ceriello. A. High fructose diet decreases catalase mRNA levels in rat tissues[J]. Diabetes, 1999,48:353-357.
